U.S. PHARMACOPEIA

Search USP29  
Isoxsuprine Hydrochloride
Click to View Image
C18H23NO3·HCl 337.84

Benzenemethanol, 4-hydroxy--[1-[(1-methyl-2-phenoxyethyl)amino]ethyl]-, hydrochloride, stereoisomer.
p-Hydroxy--[1-[(1-methyl-2-phenoxyethyl)amino]ethyl]benzyl alcohol hydrochloride.
(±)-(R*)-p-Hydroxy--[(1S*)-1-[[(1S*)-1-methyl-2-phenoxyethyl]amino]ethyl]benzyl alcohol hydrochloride [579-56-6; 34331-89-0].
» Isoxsuprine Hydrochloride contains not less than 97.0 percent and not more than 103.0 percent of C18H23NO3·HCl, calculated on the dried basis.
Packaging and storage— Preserve in tight containers.
Identification—
B: Ultraviolet Absorption 197U
Solution: 50 µg per mL.
Medium: water.
C: To 1 mL of a solution (1 in 100), obtained by heating as necessary, add 3 mL of a 1 in 15 solution of sodium nitrite in 2 N sulfuric acid. Add ammonium hydroxide dropwise: a yellow precipitate is formed and it dissolves upon the addition of sodium hydroxide solution (1 in 5).
D: To 1 mL of a solution (1 in 100) add 1 mL of phosphomolybdic acid solution (1 in 100): a pale yellow to white precipitate is formed.
pH 791: between 4.5 and 6.0, in a solution (1 in 100).
Loss on drying 731 Dry it at 105 for 1 hour: it loses not more than 0.5% of its weight.
Residue on ignition 281: not more than 0.2%.
Heavy metals, Method II 231: 0.002%.
Related compounds— To 10 mg, accurately weighed in a suitable vial, add 1 mL of N-trimethylsilylimidazole, and heat at 65 for 10 minutes. Add 5 mL of isooctane, wash with one 3-mL portion of water, and allow the layers to separate. Inject a 2-µL portion of the isooctane solution into a gas chromatograph equipped with a 0.3-cm × 2.0-m glass column packed with packing S1A containing 3% liquid phase G2 and a flame-ionization detector. The column temperature is maintained at 215, and the injection port and detector are maintained at 250. The carrier gas is nitrogen, flowing at the rate of 25 mL per minute. Adjust the instrument to provide full-scale response for the major component. Inject a second 2-µL portion of the isooctane solution with the attenuator adjusted to an 8-fold increase in sensitivity, and record the chromatogram from 0.5 to 1.5 relative to the retention time of the major peak. Measure the area of all minor peaks, and correct for differences in sensitivity settings. Calculate the percentage of related compounds present taken by the formula:
100A / B,
in which A is the sum of the corrected area peaks for all minor peaks, and B is the sum of the corrected area peaks for the major and minor peaks. Not more than 2.0% is found.
Organic volatile impurities, Method V 467: meets the requirements.
Solvent— Use dimethyl sulfoxide.
Residual solvents 467: meets the requirements.
(Official January 1, 2007)
Assay— Transfer about 50 mg of Isoxsuprine Hydrochloride, accurately weighed, to a 1000-mL volumetric flask, add water to volume, and mix. Concomitantly determine the absorbances of this solution and of a Standard solution of USP Isoxsuprine Hydrochloride RS in the same medium having a known concentration of about 50 µg per mL in 1-cm cells at the wavelengths of maximum absorbance at about 269 and 300 nm, with a suitable spectrophotometer, using water as the blank. Calculate the quantity, in mg, of C18H23NO3·HCl in the Isoxsuprine Hydrochloride taken by the formula:
C(AU269 AU300) / (AS269 AS300),
in which C is the concentration, in µg per mL, of USP Isoxsuprine Hydrochloride RS in the Standard solution; and the parenthetic expressions are the differences in the absorbances of the two solutions at the wavelengths indicated by the subscripts, for the assay solution (U) and the Standard solution (S), respectively.
Auxiliary Information— Staff Liaison : Andrzej Wilk, Ph.D., Senior Scientific Associate
Expert Committee : (MDCV05) Monograph Development-Cardiovascular
USP29–NF24 Page 1207
Phone Number : 1-301-816-8305